Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05120960
What this trial is testing

A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

Who this might be right for
Brain Tumor
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00462982
What this trial is testing

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer
Memorial Sloan Kettering Cancer Center 8
Not applicableLooking for participantsNCT05378633
What this trial is testing

The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Who this might be right for
Brain MetastasesNsclc
University Hospital Heidelberg 190
Early research (Phase 1)Study completedNCT03657576
What this trial is testing

Trial of C134 in Patients With Recurrent GBM

Who this might be right for
Glioblastoma Multiforme of BrainAnaplastic Astrocytoma of BrainGliosarcoma of Brain
University of Alabama at Birmingham 19
Not applicableLooking for participantsNCT07415668
What this trial is testing

Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning

Who this might be right for
Metastases to Brain
Insel Gruppe AG, University Hospital Bern 30
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Testing effectiveness (Phase 2)Ended earlyNCT02607124
What this trial is testing

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine GliomaBithalamic High Grade Glioma
Children's Hospital Medical Center, Cincinnati 11
Large-scale testing (Phase 3)UnknownNCT00517959
What this trial is testing

SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors

Who this might be right for
Low Grade GliomasCraniopharyngiomaEpendymomas+1 more
Tata Memorial Hospital 200
Not applicableLooking for participantsNCT05819008
What this trial is testing

Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries

Who this might be right for
Traumatic Brain InjuryStrokeMultiple Sclerosis+3 more
Umeå University 350
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Large-scale testing (Phase 3)Looking for participantsNCT03550391
What this trial is testing

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Who this might be right for
Brain Metastases
Canadian Cancer Trials Group 206
Not applicableStudy completedNCT06471660
What this trial is testing

Family Caregiver Online Survey (Dementia and Swallowing Difficulties)

Who this might be right for
DementiaDysphagiaDementia Alzheimers+9 more
University of Oregon 219
Testing effectiveness (Phase 2)Ended earlyNCT01068782
What this trial is testing

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Who this might be right for
Astrocytic Tumors
Exelixis 19
Testing effectiveness (Phase 2)Study completedNCT01751308
What this trial is testing

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Who this might be right for
Malignant Solid Tumor - Malignant Nervous System Neoplasm
Sanofi 39
Early research (Phase 1)Study completedNCT03719768
What this trial is testing

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

Who this might be right for
Leptomeningeal MetastasesLeptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT00823797
What this trial is testing

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
University of Washington 45
Not applicableLooking for participantsNCT04463316
What this trial is testing

GROWing Up With Rare GENEtic Syndromes

Who this might be right for
Prader-Willi SyndromePWS-like SyndromeSilver Russel Syndrome+30 more
dr. Laura C. G. de Graaff-Herder 600
Not applicableStudy completedNCT05874050
What this trial is testing

Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.

Who this might be right for
NeurosurgeryIntracranial HemorrhagesSupratentorial Brain Tumor+1 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 160
Early research (Phase 1)Study completedNCT01703507
What this trial is testing

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Early research (Phase 1)Study completedNCT00326664
What this trial is testing

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+18 more
National Cancer Institute (NCI) 55
Next Page